Clinical trials
Acquired Immunodeficiency Syndrome trials in Zambia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2006 | 1 |
| 2015 | 1 |
| 2017 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 3 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Alabama at Birmingham | 4 |
| Columbia University | 2 |
| Johns Hopkins Bloomberg School of Public Health | 2 |
| University of Maryland, Baltimore | 2 |
| Centre for Infectious Disease Research in Zambia | 1 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 |
| Mulungushi University | 1 |
| University of Colorado, Denver | 1 |
| University of North Carolina, Chapel Hill | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 15 |
| HIV Infections | 2 |
| Tuberculosis | 2 |
| Alcohol-Related Disorders | 1 |
| Alcoholism | 1 |
| Anxiety Disorders | 1 |
| Cryptococcosis | 1 |
| Essential Hypertension | 1 |
| Hypertension | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.